Circulating antibodies directed against NO-modified self antigens in chronic neurological and rheumatismal diseases;Anticorps seriques circulants diriges contre des antigenes modifies par le NO dans les affections neurologiques et rhumatismales

Immuno-Analyse et Biologie Specialisee

Volumn 13, Issue 4, 1998, Pages 209-217

  Geffard, M ^a,e   Bodet, D ^a   Claudepierre, P ^b   Metzger, J M ^c   Sibilia, J ^d  

^a Ecole Nationale Superieure de Chimie et de Physique de Bordeaux   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c Service de rhumatologie   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e INSERM   (France)

Author keywords

Amyotrophic lateral sclerosis; Ankylosing spondylitis; Antibody; Multiple sclerosis; Nitric oxide; Rheumatoid arthritis; Serum

Indexed keywords

ANTIBODY CONJUGATE; ASPARAGINE; AUTOANTIBODY; AUTOANTIGEN; HAPTEN; HISTIDINE; NITRIC OXIDE; PHENYLALANINE; S NITROSOCYSTEINE; TRYPTOPHAN; TYROSINE;

AMYOTROPHIC LATERAL SCLEROSIS; ANKYLOSING SPONDYLITIS; ANTIBODY BLOOD LEVEL; CHRONIC DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

EID: 0032128860     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0923-2532(98)80005-7     Document Type: Review

References (35)

1. 1 Amara A, Constans J, Chaugier C, Sebban A, Dubourg L, Peuchant E, Pellegrin JL, Leng B, Conti C, Geffard M. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin Exp Immunol 1995 ; 101 : 1-6
2. 2 Amin AR, Di Cesare PE, Vyas P, Attur M, Tzeng E, Billiar TR, Stuchin SA, Abramson SB. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes : evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 1995 ; 182 : 2097-2102
3. 3 Archer S. Measurement of nitric oxide in biological models. FASEB J 1993 ; 7 : 349-60
4. 4 Arnett FC, Edworthy SM, Bloch DA, Mc Shane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 ; 31 : 315-24
5. 5 Avrameas S. Natural antibodies and autoantibodies ISI Atlas of Science/ Immunology 1988 ; 111-15
6. 6 Beal MF. Oxidative damage in neurodegenerative diseases. The Neuroscientist 1997 ; 3 : 327-33
7. 7 Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis. Ann Neurol 1994 ; 36 : 778-86
8. 8 Boullerne A, Petry KG, Meynard M, Geffard M. Indirect evidence for NO involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol 1995 ; 60 : 117-24
9. 9 Daverat P, Geffard M, Orgogozo JM. Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis. J Neuroimmunol 1989 ; 22 : 129-134
10. 10 Dawson VL, Brahmbhatt HP, Mong JA, Dawson TM. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacol 1994 ; 33 : 1425-30
11. 11 Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992 ; 51 : 1219-22
12. 12 Giovannoni G, Heales SJR, Silver NC, O'riordan J, Miller RF, Land JM, Clark JB, Thompson EJ. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J Neurol Sci 1997 ; 145 : 77-81
13. 13 Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, Ralston SH. Elevated nitric oxide production in rheumatoid arthritis. Arthritis Rheum 1996 ; 39 : 643-7
14. 14 Halliwell B. What nitrates tyrosine ? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo ? FEBS Letters 1997 ; 411 : 157-60
15. 15 Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide : a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988 ; 157 : 87-94
16. 16 Hilliquin P, Borderie D, Hernvann A, Menkes CJ, Ekindjian OG. Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum 1997 ; 40 : 1512-17
17. 17 Ialenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992 ; 211 : 177-182
18. 18 Ischiropoulos H, Zhu L, Beckman J. Peroxynitrite formation from macrophage derived nitric oxide. Arch Biochem Biophys 1992 ; 298 : 446-51
19. 19 Ischiropoulos H, Zhu L, Chen J. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992 ; 298 : 431-37
20. 20 Kubes P, Suzuki M, Granger DN. Nitric oxide : an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991 ; 88 : 4651-4655
21. 21 Mills CD. Molecular basis of «suppressor» macrophages : arginine metabolism via the nitric oxide synthase pathway. J Immunol 1991 ; 146 : 2419-2423
22. 22 Moilanen E, Vapaatalo H. Nitric oxide in inflammation and immune response. Ann Med 1995 ; 27 : 359-67
23. 23 Poser CM, Paty BW, Scheinberg L, Mc Donald I, Davis F, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtelotte WW. New diagnostic criteria for multiple sclerosis : guideliness for Research Protocols. Ann Neurology 1983 ; 13 : 227-31
24. 24 Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987 ; II : 1057-58
25. 25 Schmidt HHW, Walter U. NO at work. Cell 1994 ; 78 : 919-25
26. 26 Sherman MP, Griscavage JM, Ignarro LJ. Nitric oxide-mediated neuronal injury in multiple sclerosis. Med Hypotheses 1992 ; 39 : 143-46
27. 27 Snyder SH, Bredt D. Biological roles of nitric oxide. Sci Am 1992 ; 266 : 68-77
28. 28 Stamler JS, Simon DI, Osborne JA, Franciss S, Mullins ME, Singel D, Loscalzo J. S-Nitrosylation of proteins with nitric oxide : synthesis and characterization of biologically active compounds. Proc Natl Acad Sci 1992 ; 89 : 444-49
29. 29 Stamler JS, Singel D, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992 ; 258 : 1898-1902
30. 30 Stefanovic-Racic M, Stadler J, Evans C.H. Nitric oxide and arthritis Arthritis Rheum 1993 ; 36 : 1036-44
31. 31 Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide synthesis and ist regulation by rabbit synoviocytes. J Rheumatol 1994 ; 21 : 1892-98
32. 32 Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human g d T cells. Nature 1995 ; 375 : 155-58
33. 33 Tomer Y, Schoenfeld Y. The significance of natural autoantibodies. Immunol Investigations 1988 ; 17 : 399-424
34. 34 Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996 ; 23 : 230-36
35. 35 Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989 ; II : 997-1 000